Cat. No.: HY-108648A

2-MeSADP

(Synonyms: 2-Methylthioadenosine diphosphate; 2-Methylthio-ADP)

2-MeSADP is a P2Y receptor agonist, with an EC₅₀ of 5 nM for human P2Y12, EC₅₀ values of 19 nM and 13 nM for human P2Y13, and an EC₅₀ of 6.2 nM for mouse P2Y13. It shows slightly higher selectivity for P2Y12 over human P2Y13. 2-MeSADP triggers increases in intracellular calcium levels, Gi-mediated cAMP inhibition, adenylate cyclase inhibition and downstream signal transduction. 2-MeSADP can be used in research related to glaucoma.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

CAS No.: 34983-48-7
Formule: C₁₁H₁₇N₅O₁₀P₂S
Masse moléculaire:473.29

Stockage:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (278 KB)

2-MeSADP Chemical Structure

CAS No.: 34983-48-7

Size

Prix

Stock

Quantité

Amount: USD 0.00

* Veuillez sélectionner la quantité avant d'ajouter des articles.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Activité biologique
- Description
- IC₅₀ & Target
- Cellular Effect
- In Vitro
Chemical Information
Pureté et documentation
Références
Calculators
Help & FAQs
Classifications
Bioz

Activité biologique

Description

IC₅₀ & Target

P2Y13 Receptor

19 nM (EC₅₀)

P2Y12 Receptor

5 nM (EC₅₀)

Voir tous les produits spécifiques à Isoform P2Y Receptor :

Cellular Effect

Cell Line	Type	Value	Description	References
COS-7	EC₅₀	>10000 nM Compound: 2-MeSADP	Effective concentration to activate human Y273A mutant strain P2Y1 receptor expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration to activate human Y273A mutant strain P2Y1 receptor expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	>100000 nM Compound: 2-MeSADP	Effective concentration required for the activation of human C202A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human C202A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	>100000 nM Compound: 2-MeSADP	Effective concentration required for the activation of human R128A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human R128A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	>100000 nM Compound: 2-MeSADP	Effective concentration required for the activation of human R287E mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human R287E mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	>100000 nM Compound: 2-MeSADP	Effective concentration required for the activation of human R310A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human R310A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	>100000 nM Compound: 2-MeSADP	Effective concentration required for the activation of human S314A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human S314A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	1.27 nM Compound: 2-MeSADP	Effective concentration required for the activation of wild-type P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of wild-type P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	1.58 nM Compound: 2-MeSADP	Effective concentration required for the activation of human S317A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human S317A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	100 nM Compound: 2-MeSADP	Effective concentration required for the activation of human H277A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human H277A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	11.2 nM Compound: 2-MeSADP	Effective concentration required for the activation of human T222A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human T222A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	11.7 nM Compound: 2-MeSADP	Effective concentration required for the activation of human S314T mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human S314T mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	12.6 nM Compound: 2-MeSADP	Effective concentration required for the activation of human Y136A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human Y136A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	145 nM Compound: 2-MeSADP	Effective concentration required for the activation of human D204E mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human D204E mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	14800 nM Compound: 2-MeSADP	Effective concentration required for the activation of human R287A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human R287A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	15 nM Compound: 2-MeSADP	Effective concentration to activate human Y306A mutant strain P2Y1 receptor expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration to activate human Y306A mutant strain P2Y1 receptor expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	15.9 nM Compound: 2-MeSADP	Effective concentration required for the activation of human H132A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human H132A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	15.9 nM Compound: 2-MeSADP	Effective concentration required for the activation of human T221A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human T221A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	16 nM Compound: 2-MeSADP	Effective concentration to activate human Y203F mutant strain P2Y1 receptor expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration to activate human Y203F mutant strain P2Y1 receptor expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	17.5 nM Compound: 2-MeSADP	Effective concentration required for the activation of human K198A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human K198A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	17200 nM Compound: 2-MeSADP	Effective concentration required for the activation of human E209A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human E209A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	1790 nM Compound: 2-MeSADP	Effective concentration required for the activation of human K280A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human K280A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	18.2 nM Compound: 2-MeSADP	Effective concentration required for the activation of human F131A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human F131A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	19 nM Compound: 2-MeSADP	Effective concentration to activate human Y306F mutant strain P2Y1 receptor expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration to activate human Y306F mutant strain P2Y1 receptor expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	2.2 nM Compound: 2-MeSADP	Effective concentration required for the activation of wild-type P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate is determined in separate experiment Effective concentration required for the activation of wild-type P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate is determined in separate experiment	[PMID: 15481977]
COS-7	EC₅₀	2.5 nM Compound: 2-MeSADP	Effective concentration required for the activation of human K196A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human K196A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	2.6 nM Compound: 2-MeSADP	Effective concentration required for the activation of human R301A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human R301A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	20.7 nM Compound: 2-MeSADP	Effective concentration required for the activation of human F226A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human F226A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	3 nM Compound: 2-MeSADP	Effective concentration to activate wild-type P2Y1 receptor expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration to activate wild-type P2Y1 receptor expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	3.2 nM Compound: 2-MeSADP	Effective concentration required for the activation of human E209D mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human E209D mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	3.6 nM Compound: 2-MeSADP	Effective concentration required for the activation of human D208A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human D208A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	3.9 nM Compound: 2-MeSADP	Effective concentration required for the activation of human D289A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human D289A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	4.7 nM Compound: 2-MeSADP	Effective concentration required for the activation of human R195A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human R195A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	4.9 nM Compound: 2-MeSADP	Effective concentration required for the activation of human E209R mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human E209R mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	418 nM Compound: 2-MeSADP	Effective concentration required for the activation of human R310K mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human R310K mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	455 nM Compound: 2-MeSADP	Effective concentration required for the activation of human Q307A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human Q307A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	5.9 nM Compound: 2-MeSADP	Effective concentration required for the activation of human K125A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human K125A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	5160 nM Compound: 2-MeSADP	Effective concentration required for the activation of human C296A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human C296A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	5290 nM Compound: 2-MeSADP	Effective concentration required for the activation of human R287Q mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human R287Q mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	595 nM Compound: 2-MeSADP	Effective concentration required for the activation of human D204N mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human D204N mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	6 nM Compound: 2-MeSADP	Effective concentration to activate human Y273F mutant strain P2Y1 receptor expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration to activate human Y273F mutant strain P2Y1 receptor expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	66.5 nM Compound: 2-MeSADP	Effective concentration required for the activation of human D204A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human D204A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	7.8 nM Compound: 2-MeSADP	Effective concentration required for the activation of human R212A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human R212A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	74.9 nM Compound: 2-MeSADP	Effective concentration required for the activation of human R287K mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human R287K mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	8.6 nM Compound: 2-MeSADP	Effective concentration required for the activation of human E209Q mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human E209Q mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	9.2 nM Compound: 2-MeSADP	Effective concentration required for the activation of human R285A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human R285A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	9.8 nM Compound: 2-MeSADP	Effective concentration required for the activation of human D300A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human D300A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	IC₅₀	150 nM Compound: 2-MeSADP	Inhibition concentration required against human Y306A mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand Inhibition concentration required against human Y306A mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand	[PMID: 15481977]
COS-7	IC₅₀	22 nM Compound: 2-MeSADP	Inhibition concentration required against human Y273A mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]-MRS2279 as radioligand Inhibition concentration required against human Y273A mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]-MRS2279 as radioligand	[PMID: 15481977]
COS-7	IC₅₀	24 nM Compound: 2-MeSADP	Inhibition concentration required against wild type strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]-MRS2279 as radioligand Inhibition concentration required against wild type strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]-MRS2279 as radioligand	[PMID: 15481977]
COS-7	IC₅₀	260 nM Compound: 2-MeSADP	Inhibition concentration required against human Y203F mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand Inhibition concentration required against human Y203F mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand	[PMID: 15481977]
COS-7	IC₅₀	360 nM Compound: 2-MeSADP	Inhibition concentration required against human Y306F mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand Inhibition concentration required against human Y306F mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand	[PMID: 15481977]
COS-7	IC₅₀	40 nM Compound: 2-MeSADP	Inhibition concentration required against human Y273F mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand Inhibition concentration required against human Y273F mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand	[PMID: 15481977]
COS-7	EC₅₀	>10000 nM Compound: 2-MeSADP	Effective concentration to activate human Y203A (EL2) mutant strain P2Y1 receptor expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration to activate human Y203A (EL2) mutant strain P2Y1 receptor expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	EC₅₀	>100000 nM Compound: 2-MeSADP	Effective concentration required for the activation of human C124A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate Effective concentration required for the activation of human C124A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate	[PMID: 15481977]
COS-7	IC₅₀	>10000 nM Compound: 2-MeSADP	Inhibition concentration required against human Y203A (EL2) mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand Inhibition concentration required against human Y203A (EL2) mutant strain P2Y1 receptor expressed in COS-7 cells is determined using [3H]MRS2279 as radioligand	[PMID: 15481977]
HEK293	EC₅₀	0.1 μM Compound: 2-MeS-ADP	Activity against rat P2Y1-GFP transfected in HEK293 cells by intracellular calcium increase Activity against rat P2Y1-GFP transfected in HEK293 cells by intracellular calcium increase	[PMID: 16539385]

In Vitro

2-MeSADP (Serial dilutions) potently activates human SP174 (P2Y13) in HEK293-EBNA cells cotransfected with Gαq/i3, with an EC₅₀ of 19 nM, making it one of the most potent ligands tested for this receptor^[1].
2-MeSADP (Serial dilutions) potently activates mouse SP174 (P2Y13) in HEK293-EBNA cells cotransfected with Gαq/i3, with an EC₅₀ of 6.2 nM, showing higher potency at the murine receptor than the human ortholog^[1].
2-MeSADP (Serial dilutions; 10 min) potently inhibits forskolin-stimulated cAMP accumulation in HEK293-EBNA cells stably transfected with human SP174 (P2Y₁₃), with an EC₅₀ of 13 nM, confirming coupling of the receptor to Gαi signaling^[1].
2-MeS-ADP (Serial dilutions) potently activates human P2Y12 in HEK293-EBNA cells cotransfected with Gαq/i3, with an EC₅₀ of 5 nM, showing higher potency at P2Y12 than at the related SP174 (P2Y13) receptor^[1].
2-MeSADP (0.2 mg; 3 h) is partially susceptible to hydrolysis by alkaline phosphatase, with 87% degradation observed after a 3-hour incubation at 37 °C^[2].
2-MeSADP (40 mM; up to 24 h) exhibits moderate metabolic stability in human blood serum, with a half-life of 23.5 h at 37 °C^[2].
2-MeSADP (multiple concentrations) potently activates the turkey P2Y1 receptor expressed in human 1321N1 astrocytoma cells, inducing intracellular Ca ²⁺ mobilization with an EC₅₀ of 0.0025 μM^[2].
2-MeSADP (log M values of -7 to -5.5) induces aggregation and shape change in human platelets, and is 3-5 times more potent as an aggregating agent than ADP^[4].
2-MeSADP (log M values of -9 to -7; 2 min) potently inhibits PGE1-stimulated cyclic AMP accumulation in human platelets, with half-maximal inhibition at 6 nM in platelet-rich plasma and 2 nM in washed platelets, and is 150-200 times more potent than ADP for this effect^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Chemical Information

CAS No. 34983-48-7
Masse moléculaire 473.29
Formule C₁₁H₁₇N₅O₁₀P₂S
SMILES

O[C@H]1[C@@H](O)[C@H](N2C=NC3=C2N=C(SC)N=C3N)O[C@@H]1COP(OP(O)(O)=O)(O)=O
Synonyms

2-Methylthioadenosine diphosphate; 2-Methylthio-ADP
Livraison

Room temperature in continental US; may vary elsewhere.
Stockage

Please store the product under the recommended conditions in the Certificate of Analysis.

Pureté et documentation

Select Batch:

Pureté: 99.98%

Assay: 99.98%

ee.: 99.98%

Fiche technique (278 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Instruction de manipulation (2659 KB)

Références

[1]. HY-108648A-2.pdf [Content Brief]

[2]. HY-108648A-4.pdf [Content Brief]

[3]. Sak K, et al. A retrospective of recombinant P2Y receptor subtypes and their pharmacology. Arch Biochem Biophys. 2002;397(1):131-136. [Content Brief]

[4]. HY-108648A-3.pdf [Content Brief]

Calculators

Calculateur de molarité

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Calculateur de dilution

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

Nom du produit:
Cat. No.:
Quantité:
MCE Japan Authorized Agent:

Nom du produit:
CAS No.:
Species:
Pureté:
Quantité:

2-MeSADP

Voir tous les produits spécifiques à Isoform P2Y Receptor

Activité biologique

Chemical Information

Pureté et documentation

Références

Calculators

Help & FAQs

2-MeSADP Related Classifications

HY-108648A Related Classifications